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Abstract
Background: Loss to follow-up in randomised controlled trials reduces statistical power and increases the potential
for bias. Almost half of all trials fail to achieve their follow-up target. Statistical methods have been described for
handling losses to follow-up and systematic reviews have identified interventions that increase follow-up. However,
there is little guidance on how to develop practical follow-up procedures. This paper describes the development of
follow-up procedures in a pilot randomised controlled trial of a sexual health intervention that required participants
to provide and return questionnaires and chlamydia test samples in the post. We identified effective methods to
increase follow-up from systematic reviews. We developed and tested prototype procedures to identify barriers to
follow-up completion. We asked trial participants about their views on our follow-up procedures and revised the
methods accordingly.
Results: We identified 17 strategies to increase follow-up and employed all but five. We found that some postal
test kits do not fit through letterboxes and that that the test instructions were complicated. After identifying the
appropriate sized test kit and simplifying the instructions, we obtained user opinions. Users wanted kits to be sent
in coloured envelopes (so that they could identify them easily), with simple instructions and questionnaires and
wanted to be notified before we sent the kits. We achieved 92 % (183/200) overall follow-up for the postal
questionnaire at 1 month and 82 % (163/200) at 12 months. We achieved 86 % (171/200) overall follow-up for the
postal chlamydia test at 3 months and 80 % (160/200) at 12 months.
Conclusions: By using established methods to increase follow-up, testing prototype procedures and seeking user
opinions, we achieved higher follow-up than previous sexual health trials. However, it is not possible to determine
if the increase in response was due to our follow-up procedures.
Trial registration: Current Controlled Trials ISRCTN02304709 Date of registration: 27 March 2013.
Keywords: Young people, Response rates, Follow-up, Postal questionnaire, Postal test kit, Randomised controlled
trial, Sexually transmitted infections, Sexual health, mHealth
Background
Loss to follow-up in randomised controlled trials (RCTs)
reduces statistical power and increases the potential for
bias. Bias can occur when loss to follow-up is associated
with the outcomes, such as when those lost have poorer
outcomes then those retained. In order to explore the
potential bias introduced, a range of plausible assump-
tions about outcomes in those lost to follow-up can be
made [1]. A systematic review of trials reported in top
medical journals found that when different plausible as-
sumptions are made, the interpretation of trial results
could change [1].
Almost half of all trials fail to achieve their follow-up
target [2] and achieving high follow-up when collecting
data on sensitive topics such as sexual health is particu-
larly challenging. In sexual health research, response
rates for self-reported data and test kits have been rela-
tively low in both RCTs and surveys. The National
Survey of Sexual Attitudes and Lifestyles (Natsal) study
in the UK, a probability sample household survey,
achieved 57.7 % response rate for face-to-face interviews
and 60 % response for urine samples requested (not all
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responders were asked to provide a sample) [3]. A UK
cross-sectional population-based study reported an uptake
of chlamydia postal screening of 31.5 % in people aged
16–24 (the chlamydia screening studies ‘ClaSS’ project)
[4, 5]. A pilot trial of a sexual health website intervention
for young people (‘Sexunzipped’) achieved 45 % follow-
up using chlamydia postal test kits and 72 % for self-
reported data at 3 months [6].
Effective interventions for increasing follow-up have
been developed and evaluated [7–12]. However, there is
little guidance on how to develop practical follow-up
procedures. Specifically, there is no guidance for devel-
oping follow-up procedures for RCTs on sensitive topics.
Intervention development and pilot trial
The National Institute for Health Research Health Tech-
nology Assessment Programme (NIHR HTA) commis-
sioned us to develop a mobile phone-based intervention
to promote safer sex behaviour in young people aged
16–24 in the UK and to conduct a pilot RCT of the
intervention. Key parameters for judging the success of
the research were the acceptability of the intervention
and the feasibility of recruitment and follow-up in a
RCT. We conducted formative research, which included
focus group discussions (FGD) to inform the interven-
tion content.
In the pilot trial we recruited participants from seven
sexual health services in London, Manchester, Cambridge-
shire, Norfolk, Maidstone and Hull. People aged 16–24
who had had a recent positive chlamydia test result or had
reported unsafe sex in the last year (defined as more than
one partner and at least one occasion of unprotected sex)
were eligible to take part. Recruitment staff invited eligible
participants to take part in the study either at the site or
by telephone. Participants provided informed consent
either written or through the secure online database. Par-
ticipants were randomised by a remote randomisation
service, ensuring allocation concealment. Intervention or
control group messages were sent from our automated
system according to allocation. The intervention consisted
of up to 63 text messages and employed 12 behaviour
change techniques [13]. The messages were tailored
according to infection status at enrolment and gender.
Control participants received monthly messages about the
importance of trial participation. We collected self-
reported sexual health outcome data using postal ques-
tionnaires at 1 month and 12 months and chlamydia
postal testing kits at 3 months and 12 months. Partici-
pants had the option of completing follow-up by attending
the clinic or completing the questionnaire online, by text
message or email.
We randomised 200 people between 9 September 2013
and 26 November 2013. Sixty-six percent of eligible
participants joined the trial. The intervention develop-
ment and pilot trial details are reported elsewhere [14].
In order to minimise bias in our trial we aimed to maxi-
mise follow-up. In this paper we describe the approach we
used to develop the pilot trial follow-up procedures.
Methods
Ethical approval for the intervention development phase
of the project was granted by NRES Committee
London-Bentham on 6 November 2012 (REC reference
number 12/LO/1329). Ethical approval for the pilot trial
was granted by NRES Committee South East Coast-
Surrey on 26 July 2013 (REC reference number 13/LO/
1001).
We developed our trial follow-up procedures in three
steps.
Step 1. Identifying evidence-based effective strategies to
increase follow-up in trials
We searched the Cochrane Library for systematic re-
views of trials of interventions designed to increase
follow-up in research. We identified methods for which
there was there was evidence of success in increasing
response to postal follow-up requests in trials. We devel-
oped prototype follow-up procedures incorporating the
effective strategies identified.
Step 2. Testing prototype follow-up procedures and
materials
We obtained sample postal test kits routinely used in
our trial recruitment sites (Cambridgeshire, Manchester
and London) and test kits used in the NHS chlamydia
postal testing services. We measured London letterboxes
on central London streets and measured the test kits to
identify those that would fit through the smallest letter
boxes.
We attempted to follow the instructions that were
included in the postal test kit that would fit through the
smallest letter box. Based on this experience, we gener-
ated ideas on how to make the follow-up process easier.
We generated prototype test kits including combinations
of the original and simplified materials. We gave test kits
to volunteers from the Clinical Trials Unit (CTU) and
asked them to provide feedback on the original and
simplified materials. We also consulted with experts in
sexual health regarding the questionnaire design and
follow-up procedures.
Step 3. Consulting with users
We asked young people aged 16–-24 for their views
regarding the questionnaires and follow-up procedures
in four of the eight FGD convened to inform the devel-
opment of the intervention. We recruited FGD partici-
pants from community sexual and reproductive health
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services in South-east London, Greater Manchester and
rural Cambridgeshire. Clinic staff used convenience and
snowball sampling methods to recruit participants. The
facilitators (OM, CF, and RF) provided verbal and written
study information and obtained informed written consent
from participants. All discussions were audio-recorded.
We explored the participants’ preferences regarding inter-
vention content and trial follow-up procedures.
As part of the pilot trial, we conducted phone inter-
views with participants [15]. The pilot trial consent form
included an optional tick box where the participant
could consent to be contacted regarding participation in
the interview study. One hundred and sixty-seven partic-
ipants consented to be contacted for an interview. We
purposively sampled pilot trial participants 2 to 3 weeks
after enrolment so that the interview sample varied
according to age, gender, sexually-transmitted infection
(STI) test result at enrolment, location (urban/rural) and
whether they had been allocated to the intervention or
control group. We gave participants verbal and written
information about the study and obtained informed writ-
ten consent either by email or text message. All the partic-
ipants that we contacted agreed to participate (n = 20).
We conducted follow-up phone interviews with the same
participants after sending the 3-month test kits. We asked
participants for their views on the trial materials and
follow-up procedures. All interviews were audio-recorded.
We conducted a descriptive analysis after taking notes on
the recordings.
Results
Step 1. Effective strategies to increase postal follow-up
The follow-up strategies where there is evidence of increas-
ing the odds of response are reported in Additional file 1
[7–12, 16]. We employed all but five of the 17 strategies.
Step 2. Testing the prototype follow-up procedures
Only one test kit would fit through the smallest London
letterbox (approximately 19 cm × 2.5 cm). This kit was
provided by a laboratory diagnostic company, which
contained pre-packaged components. Contents of the
test kit included nine items (see Additional file 2). The
components in the test kit included non-essential items,
which we removed. The instructions for women could
be confusing because the kit contained both the swab
and the urine tube but they were required to provide
only one sample.
Of the 12 CTU volunteers who were asked to provide
a urine sample in the pouch, only one was able to use it
successfully. Female volunteers did not express a prefer-
ence for providing urine or vaginal swab samples. They
preferred the simplified instructions and suggested that
we include a statement in the postal letters about the
importance of their participation so that they would feel
‘proud’ about doing something good.
Experts in sexual health questionnaire design suggested
that we order the key questions, those on treatment and
sexual health behaviour, first.
Step 3. User views
We conducted eight FGD with 82 participants. The me-
dian age of FGD participants was 17 years with 32 men
and 50 women; 39 were from London, eight from Man-
chester and 35 from rural Cambridgeshire (see Additional
file 3). Participants wanted the questionnaires to be as
short as possible. They had no objections to the prototype
questionnaire design and content. They reported that the
study materials should be identifiable only to them and
suggested using a coloured postal envelope. They thought
that the simplified instructions were clear. Participants
asked to receive a text or phone call before we sent the
materials so they would know to look out for them. They
were concerned that sending materials by recorded deliv-
ery could call attention to the post and that parents would
ask questions. Women approved of the vaginal swab only,
rather than providing a choice between swab and urine
sample.
Final follow-up procedures
The results of steps 1–3 informed the final follow-up
procedures.
Materials
Questionnaires Our follow-up questionnaire was two
pages long. Research evidence and feedback from the
target group suggests that questionnaires should be as
short as possible [7, 9–11, 16]. In accordance with guid-
ance from our consultation with experts and evidence
from Edwards et al. (2009), we ordered the key questions
on treatment and sexual behaviour first [7]. We did not
include personal details on the questionnaires and in-
cluded a statement about confidentiality [7]. We offered
an online questionnaire as an alternative to postal com-
pletion. Participants had the opportunity to reply to key
questions by text and email if they had not responded
after the final paper mailing.
Postal test kit We selected a postal test kit that would
fit through the smallest letterbox that we measured. The
kits contained only essential components (see Additional
file 4). We included a swab only for women. We used
the simplified instruction slips. We used a pared-down
laboratory slip that only required participants to write
the date the sample was collected. Participants had the
option of providing their test sample at the clinic.
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Letters The letters were as short as possible [7, 9–11,
16] (see Additional file 5 for a sample follow-up letter).
The template was formal but the tone was casual [16].
The letters included a statement saying that the recipi-
ent was helping to improve the health of young people,
a National Health Service/National Institute of Heath
Research logo and the Trial Coordinator’s University
address [7].
Envelopes and postage We sent all correspondences in
blue envelopes and used first class outward and incoming
postage [7, 16]. We did not send the post by recorded
delivery or add a ‘teaser’ on the envelope (a ‘teaser’ is a
statement indicating that that there may be a benefit to
opening) because of its potential to call attention to partic-
ipants’ participation in the study, which could comprom-
ise confidentiality [7].
Mailings and incentives We notified all participants by
text message before the initial mailing of the question-
naire and test kit [7, 16]. All initial mailings of the ques-
tionnaire and test kit included £5 unconditional cash
incentive [7, 10, 12]. We sent £20 cash to all participants
who returned the chlamydia test sample [7, 8, 12, 16].
While there is no evidence from systematic reviews for
sending additional cash after receipt, our experience in
the txt2stop trial was that additional participants did re-
spond to this [17]. We contacted non-responders by
phone, text messages and email, unless they opted out of
further follow-up at any stage [7–9, 16].
Month 1 questionnaire
The initial questionnaire posting included a £5 cash uncon-
ditional incentive [7, 10, 12]. We sent an email message,
which included a link to the online questionnaire, within a
week after the initial questionnaire posting [7–9, 16]. We
posted the questionnaire again, 2 to 3 weeks later, and sent
a second email within a week after this [7, 16]. The third
paper mailing included a statement in the letter saying that
we would send an additional £10 if we received it within
2 weeks [7, 8, 12, 16]. The fourth paper mailing included a
statement in the letter that we would enter participants into
a £50 prize draw if they returned the questionnaire within
2 weeks [7, 8, 12, 16]. All responders were eligible for the
prize draw. Finally, we emailed, texted and posted key out-
come questions to non-responders [7–9, 16].
Month 3 chlamydia test
The initial postal test kit included a £5 cash unconditional
incentive [7, 10, 12]. All letters mentioned that they would
receive £20 if they returned the sample [7, 8, 12, 16]. We
sent the test kit to non-responders a further three times
[7, 16]. The fourth mailing included a statement in the
letter saying that they would be entered into a prize draw
for £50 if we received it within 2 weeks [7, 8, 12, 16]. At
each mailing, we followed up with participants by phone
and email [7–9]. We sent the test kit to non-responders
once a month [7, 16].
Month 12 questionnaire and chlamydia test
We sent the initial 12-month questionnaire and test kit
together with a £10 cash unconditional incentive [7, 10,
12]. All letters mentioned that they would receive £20 if
they returned the sample [7, 8, 12, 16]. The initial letter
included a statement saying that we would enter partici-
pants into a £50 prize draw if they returned both the ques-
tionnaire and test [7, 8, 12, 16]. We phoned and sent an
email message, which included a link to the online ques-
tionnaire, around 3 weeks after the initial mailing [7–9,
16]. We sent the questionnaire and test kit to non-
responders a further three times [7–9, 16]. At each mail-
ing, we followed up with participants by phone and email
[7–9]. We sent the test kit to non-responders once a
month [7, 16]. We emailed, texted and posted one or two
key outcome questions to questionnaire non-responders
(according to their chlamydia status at enrolment) [7–9,
16].
Response
Ninety-two percent (183/200) provided questionnaire
outcome data at 1 month, 86 % (171/200) provided a
chlamydia test sample at 3 months, 82 % (163/200) pro-
vided questionnaire outcome data and 80 % (160/200)
provided a chlamydia test sample at 12 months (see
Additional file 6).
User views of the final follow-up procedures
We interviewed 17 of the original 20 main pilot trial inter-
view participants within 2 months of sending the 3-month
postal STI testing kits (see Additional file 7). Nine follow-
up interview participants tested positive at enrolment.
None of the participants had any criticisms of the proce-
dures. They thought that the pre-notification served as a
reminder to look in the post. Participants mentioned that
the blue envelope helped them recognise that it was study
material. One said that the letters were polite in that we
were not telling them that they had to send it back and
another appreciated that they were short and to the point.
Most participants thought that the instructions were easy
to follow and most did not have any criticisms of the pos-
tal test kit. One participant said that initially they were not
clear whether they should post the box on its own or
inside an envelope. Another suggested including a urine
collection pouch. One participant said that she initially
had difficulty opening the swab. Another suggested that
we include a condom in the kit.
Most participants said that they would have returned
the questionnaire and chlamydia sample even if they were
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not offered an incentive. Some indicated that the motivat-
ing factor was their health rather than the money. A few
participants mentioned that the unconditional £5 moti-
vated them to return it and another wanted to return it
because we ‘treated’ them and said they would have pro-
crastinated without it. Women preferred the swab sample
collection method and no participants mentioned that
they would rather have had a choice (swab or urine).
Discussion
Summary of the main findings
This paper describes how we developed follow-up proce-
dures for the pilot RCT of our sexual health intervention
delivered by text message. We used evidence-based
methods, tested prototype procedures and consulted
with users. We achieved 92 % (183/200) overall follow-
up for the self-reported data at 1 month and 82 % (163/
200) at 12 months. We achieved 86 % (171/200) follow-
up for the chlamydia test at 3 months and 80 % (160/
200) at 12 months.
Comparisons with other studies
This pilot trial’s follow-up response for return of postal
chlamydia test samples is high when compared to similar
trials, screening initiatives and collection of self-reported
sexual health data [4, 6]. The chlamydia screening studies
(‘ClaSS’) project [4, 5] used steps described in this paper
such as choosing a test kit that would fit through a ‘stand-
ard’ letterbox and testing the kit with the target group
[18]. However, the researchers evaluated interventions to
increase follow-up after the project. Our response may be
higher than the ‘ClaSS’ project because our participants
agreed to provide follow-up data when they were re-
cruited, we offered unconditional incentives and included
only essential test kit components. The ‘Sexunzipped’ trial
used evidence-based methods to increase postal follow-up
response [6]. Response in this trial may have benefitted
from testing all the trial procedures and consulting with
the target group [17].
We developed follow-up procedures in a similar way
in the smoking cessation txt2stop pilot and main trial
[17, 19]. The pilot trial achieved 96 % response for self-
reported data at 1 month and 92 % at 6 months [19]. In
the main trial, we achieved 95 % (5524/5800) response
for self-reported data and 81 % (542/666) response for
postal salivary cotinine tests at 6 months [17]. An earlier
trial that did not use a similar approach to develop
follow-up procedures only achieved 74 % response for
self-reported data collected at 6 months [20].
Limitations
We describe a single case study using three steps to de-
velop follow-up procedures. The steps are not guaranteed
to produce useful information. For example, researchers
may identify barriers in step 2, but it may not be possible
to overcome the barriers when resources are limited. Con-
sulting with the target group could be challenging when
administering a multi-site international trial from a central
location. We did not test the kits with young people in
step 2, which could have been beneficial. Our search for
strategies to increase postal follow-up involved searching
the Cochrane Library only. Researchers who adopt our
method could benefit from searching a range of databases.
Implications of findings
Our case study suggests that our approach could increase
follow-up in trials. Previous work has highlighted the
problems with missing data, and its reporting and hand-
ling [1, 21]. Our approach aims to boost the number of
outcome events recorded, minimising bias and increasing
statistical power. An advantage of this approach is that
researchers can make fewer post-hoc assumptions about
outcomes in participants lost to follow-up. Some of the
specific follow-up procedures that we used could be rele-
vant to other trials on sensitive topics with young people
(such as using coloured envelopes). By designing accept-
able and effective follow-up procedures at the outset of
trials, researchers could avoid spending time and re-
sources deploying less effective follow-up procedures.
Conclusions
The approach described in this paper gives researchers an
additional tool to minimise losses to follow-up in trials.
Our results show that a high follow-up to self-reported
data in questionnaires and postal test kits can be achieved,
even in sensitive areas such as sexual health.
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